AM El-Kady, A S. Hassan, K Mohamed… - PLOS Neglected …, 2023 - journals.plos.org
Background Although, approximately 30% of the world's population is estimated to be infected with Toxoplasma gondii (T. gondii) with serious manifestations in …
M Omar, BE Abaza, E Mousa, SM Ibrahim… - Journal of Parasitic …, 2021 - Springer
Toxoplasmosis is one of the widest spread parasitic infections which is caused by Toxoplasma gondii protozoon. Many experimental studies have evaluated the effect of …
FM Arafa, NMFH Mogahed… - Pathogens and Global …, 2023 - Taylor & Francis
Toxoplasmosis is an opportunistic infection caused by the coccidian Toxoplasma gondii which represents a food and water contaminant. The available chemotherapeutic agents for …
Latent toxoplasmosis mostly reactivates which could result in acute encephalitis. Chronic toxoplasmosis treatments are severely constrained by Toxoplasma cyst resistance. Novel …
Toxoplasma gondii is a zoonotic intracellular protozoan parasite and its therapeutic limitations are one of its major problems. L-citrulline is an organic compound that has …
TM Almallah, SI Khedr, KA El Nouby, SS Younis… - Parasitology …, 2023 - Springer
Toxoplasmosis is an immunologically complex disease, particularly in immunocompromised patients. Although there are several therapeutic regimens for such disease, the majority of …
NM Habib, MM Morcoss - Microchemical Journal, 2024 - Elsevier
Two eco-friendly chromatographic methods were used to simultaneously determine Spiramycin (SPR) and Metronidazole (MTR) in their pure forms and pharmaceutical …
HA Rashed, A Abdel-Bary, EA Elmorsy - Parasitology Research, 2024 - Springer
Side effects and low efficacy of current anti-toxoplasmosis therapeutics against encysted bradyzoites necessitate research into alternative safe therapeutic options. The safety …
AF Allam, NA Hagras, HF Farag, MM Osman… - Journal of Parasitic …, 2022 - Springer
The present study investigated the anti-Toxoplasma effect of chitosan nanoparticles [CS NPs], spiramycin, spiramycin co-administered with metronidazole and spiramycin-CS NPs …